16 December 2020
Pill Connect expands its team with the appointment of Richard Hall as Director of Quality
Pill Connect (formerly known as Elucid Mhealth), a world leader in medicine adherence monitoring and data capture on patient compliance, has expanded its team with the appointment of Richard Hall as Director of Quality. This follows the recent successful funding raise involving...
8 December 2020
Catapult Ventures invests in OVO Biomanufacturing to improve the manufacturing efficiency of viral vaccines and gene therapies
3rd December 2020 - Alderley Park, UK. OVO Biomanufacturing today announced the completion of a new funding round to develop its novel technology platform to improve the manufacturing efficiency for viral vaccines and gene therapies. The funding came from the GM&C Life...
26 November 2020
Exciting new collaboration to develop fully synthetic animal-free scaffolds
Three UK biotechnology companies will combine research expertise to develop fully synthetic animal-free scaffolds overcoming barriers in sustainable and scalable organoid culture in a project funded by Innovate UK. Cardiff-based organoid company, Cellesce, Peptide 3D scaffold...
24 November 2020
Maven Equity Finance NPIF invests alongside Catapult in digital healthcare consent platform Flynotes
A Manchester-based digital healthcare consent platform has secured funding from NPIF - Maven Equity Finance. Flynotes is behind a platform which provides a digital alternative to the paper-based consent and disclosure process. Having developed its product, the company is...
23 November 2020
Maxwellia looking into daily contraceptive Rx-To-OTC switch
As calls for a non-prescription daily contraceptive pill grow in the UK, switch incubator Maxwellia suggests an Rx-to-OTC reclassification of the widely-used progestogen only pill may be one of its first "switch-in-a-box" projects. Responding to a growing demand in the UK for...
18 November 2020
Digi.me partners with Gendius to allow users to connect their health records to its smart diabetes management platform
Digi.me is partnering with British digital health start-up Gendius to allow users to connect their health records to its smart diabetes platform, Intellin®. The deal will mean that digi.me users in the UK will be able to download and consent to share their NHS GP health...
17 November 2020
Cytox publishes research showing genoSCORE-LAB test can predict risk of cognitive decline due to Alzheimer’s without invasive procedures
genoSCORE™-LAB a new genetic test to launch in 2020 enables early assessment of patients with cognitive complaints from a simple saliva or blood sample … 17th November 2020: Oxford and Manchester, UK. Cytox Ltd, which provides non-invasive, risk assessment and patient...
9 November 2020
The Medication Adherence Expertise Center and Pill Connect’s smart adherence system help patients with TB take their medication regularly
A pilot trial at The Medication Adherence Expertise Center of the University Medical Center Groningen in the Netherlands is determining whether Pill Connect’s smart bottle system can support patients with tuberculosis (TB) with their medication adherence. TB remains one of...
5 November 2020
Infex Therapeutics and LifeArc announce collaboration to defeat superbugs
Infex Therapeutics has combined forces with medical research charity, LifeArc, to develop the next generation of drugs to treat serious infections caused by superbugs. The collaboration will see Infex Therapeutics develop innovative antimicrobial compounds against...
4 November 2020
Biorelate - AI-based drug discovery tool free access extended
As the world enters a new wave of lockdowns, Biorelate, a Manchester-based AI start up, extends its free use of Galactic to all researchers. To aid researchers as they try to adapt to the ‘new normal’ caused by COVID-19, Biorelate has been offering free use of its...